|
Median age, y (range)
|
69 (23–83)
|
65 (22–81)
|
|
Male, n (%)
|
8 (80)
|
10 (50)
|
|
White, n (%)
|
8 (80)
|
20 (100)
|
|
ECOG performance status, n (%)
|
|
0
|
4 (40)
|
3 (15)
|
|
1
|
6 (60)
|
15 (75)
|
|
2
| |
2 (10)
|
|
Disease stage, n (%)
|
|
I
|
0
|
2 (10)
|
|
II
|
1 (10)
|
3 (15)
|
|
III
|
4 (40)
|
3 (15)
|
|
IV
|
5 (50)
|
12 (60)
|
|
Prior treatment with radiation therapy, n (%)
|
3 (30)
|
6 (30)
|
|
Prior treatment with systemic therapy, n (%)
|
10 (100)
|
20 (100)
|
|
Median number of prior regimens (range)
|
4.5 (1–8)
|
3.5 (1–9)
|
|
Prior treatment with surgery, n (%)
|
3 (30)
|
3 (15)
|
|
History of cancer(s) other than current cancer, n (%)
|
5 (50)
|
3 (15)
|
